FAST (N = 332) | SCOT (N = 181) | PATHWAY 1 (N = 93) | PATHWAY 2 (N = 210) | PATHWAY 3 (N = 199) | Overall (N = 1,015) | ||
---|---|---|---|---|---|---|---|
Offered incentive payment, n (%) | 158 (47.6%) | 84 (46.4%) | 46 (49.5%) | 101 (48.1%) | 92 (46.2%) | 481 (47.4%) | |
Not offered incentive payment, n (%) | 174 (52.4%) | 97 (53.6%) | 47 (50.5%) | 109 (51.9%) | 107 (53.8%) | 534 (52.6%) | |
Number of responses to first invitation letter | Positive | ||||||
Incentive offer | 68 (43.0%) | 34 (40.5%) | 5 (10.9%) | 19 (18.8%) | 26 (28.3%) | 152 (31.6%) | |
No incentive offer | 54 (31.0%) | 31 (32.0%) | 7 (14.9%) | 19 (17.4%) | 21 (19.6%) | 132 (24.7%) | |
% change with Incentive ((95% CI)) | 12.0% | 8.5% | −4.0% | 1.4% | 8.7% | 6.9%* (1.35 to 12.40) | |
Negative | |||||||
Incentive offer | 40 (25.3%) | 15 (17.9%) | 14 (30.4%) | 30 (29.7%) | 23 (25.0%) | 122 (25.4%) | |
No incentive offer | 49 (28.2%) | 16 (16.5%) | 16 (34.0%) | 37 (33.9%) | 39 (36.4%) | 157 (29.4%) | |
% change with incentive ((95% CI)) | −2.9% | −1.4% | −3.6% | −4.2 | −11.4% | −4.0% (−1.47 to 9.47) | |
No response | |||||||
Incentive offer | 50 (31.6%) | 35 (41.7%) | 27 (58.7%) | 52 (51.5%) | 43 (46.7%) | 207 (43.0%) | |
No incentive offer | 71 (40.8%) | 50 (51.5%) | 24 (51.1%) | 53 (48.6%) | 47 (43.9%) | 245 (45.8%) | |
% change with incentive ((95% CI)) | −9.2% | −9.8% | 7.6% | 2.9% | 2.8% | −2.8% (−3.27 to 8.92) | |
Number of patients signing a consent form | Incentive offer | 58 (36.7%) | 26 (30.9%) | 3 (6.5%) | 4 (4.0%) | 9 (9.8%) | 100 (20.8%) |
No incentive offer | 41 (23.6%) | 24 (24.7%) | 4 (8.5%) | 9 (8.3%) | 6 (5.6%) | 84 (15.7%) | |
% change with incentive ((95% CI)) | 13.1% | 6.2% | −2.0% | −4.3% | 4.2% | 5.1%* (0.31 to 9.85) | |
Number of patients randomised into trial | Incentive offer | 58 (36.7%) | 26 (30.9%) | 2 (4.3%) | 3 (3.0%) | 5 (5.4%) | 94 (19.5%) |
No incentive offer | 40 (23.0%) | 24 (24.7%) | 3 (6.4%) | 6 (5.5%) | 0 | 73 (13.7%) | |
% change with incentive ((95% CI)) | 13.7% | 6.2% | −2.1% | −2.5% | 5.4%* | 5.9%* (1.30 to 10.49) |